Comparison of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in myocardial infarction patients with type 2 diabetes

被引：0
|
作者：
Tjerkaski, J. [1 ]
Ueda, P. [2 ]
Alfredsson, J. [3 ]
Erlinge, D. [4 ]
Lindahl, B. [5 ,6 ]
Mohammad, M. A. [4 ]
Omerovic, E. [7 ]
Reitan, C. [1 ]
Svensson, P. [2 ]
Jernberg, T. [1 ]
机构：
[1] Karolinska Inst, Danderyd Hosp, Stockholm, Sweden
[2] Karolinska Inst, Stockholm, Sweden
[3] Linkoping Univ, Linkoping, Sweden
[4] Lund Univ, Lund, Sweden
[5] Uppsala Univ Hosp, Uppsala, Sweden
[6] Uppsala Clin Res Ctr, Uppsala, Sweden
[7] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors: Sequential or simultaneous start?
    Goncalves, Edison
    Bell, David S. H.
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (06): : 909 - 911
  • [2] Cardiovascular effects of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: The P value and beyond
    Kloecker, David E.
    Davies, Melanie J.
    Khunti, Kamlesh
    Zaccardi, Francesco
    [J]. DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1685 - 1691
  • [3] Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis
    Mantsiou, Chrysanthi
    Karagiannis, Thomas
    Kakotrichi, Panagiota
    Malandris, Konstantinos
    Avgerinos, Ioannis
    Liakos, Aris
    Tsapas, Apostolos
    Bekiari, Eleni
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (10): : 1857 - 1868
  • [4] Sociodemographic Disparities in Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists Prescription Patterns Among Patients With Poorly Controlled Diabetes
    Antwi-Amoabeng, Daniel
    Beutler, Bryce D.
    Ghuman, Jasmine
    Ulanja, Mark B.
    Ghuman, Joban
    Gullapalli, Nageshwara
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [5] Effect of sex on sodium-glucose co-transporter-2 antagonists and glucagon-like peptide-1 agonists in heart failure
    Philip, Mevin A.
    Webb, Carolyn M.
    Chakraborty, Turja
    Collins, Peter
    [J]. ESC HEART FAILURE, 2024,
  • [6] Patients' Preferences for Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
    Banjara, Bidur
    Poudel, Nabin
    Garza, Kimberly B.
    Westrick, Salisa
    Whitley, Heather P.
    Redden, David
    Ngorsuraches, Surachat
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2022, 16 : 3415 - 3428
  • [7] The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
    Ueda, Peter
    Wintzell, Viktor
    Dahlqwist, Elisabeth
    Eliasson, Bjorn
    Svensson, Ann-Marie
    Franzen, Stefan
    Gudbjornsdottir, Soffia
    Hveem, Kristian
    Jonasson, Christian
    Melbye, Mads
    Hviid, Anders
    Svanstrom, Henrik
    Pasternak, Bjorn
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (03): : 473 - 485
  • [8] Impact of Sodium-Glucose Co-Transporter-2 Inhibition on the Efficacy and Safety of the Glucagon-like Peptide-1 Receptor Agonist Efpeglenatide in Type 2 Diabetes
    Lam, Carolyn S.
    Branch, Kelley R.
    Sattar, Naveed
    Rosenstock, Julio
    Pratley, Richard
    del Prato, Stefano
    Lopes, Renato D., Sr.
    Niemoeller, Elisabeth
    Khurmi, Nardev S.
    Baek, Seungjae
    Gerstein, Hertzel C.
    [J]. CIRCULATION, 2021, 144 (25) : E584 - E584
  • [9] Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence
    Karakasis, Paschalis
    Patoulias, Dimitrios
    Kassimis, George
    Koufakis, Theocharis
    Klisic, Aleksandra
    Doumas, Michael
    Fragakis, Nikolaos
    Rizzo, Manfredi
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (27) : 2109 - 2119
  • [10] A META-ANALYSIS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Wong, Chloe
    Yaow, Clyve Yu Leon
    Lee, Ming Hui
    Chin, Yip Han
    Ng, Cheng Han
    Khoo, Chin Meng
    Muthiah, Mark Dhinesh
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S839 - S840
12345